|
Pear Therapeutics, Inc. Warrants
Ticker Symbol: PEARWQ* CUSIP: Unknown* Exchange: NCM * If you know the CUSIP number for this security, please let us know.
* NOTE: This security is no longer trading as of 5/28/2024
Company's Online Profile
BUSINESS: Pear Therapeutics, Inc. is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.
|
Notes: Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment
|
Previous Ticker Symbol: PEARW Changed: 4/17/2023
Previous Name: Thimble Point Acquisition Corp Changed: 12/03/2021
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Address and Phone Numbers |
| Address: 200 State Street, 13th Floor, Boston, MA 02109 |
| Main Phone Number |
617-925-7848 |
| Fax Number |
Not Available |
| Corporate Communications
Meara Murphy
|
617-925-7848
|
| CEO - Elon S. Boms |
CFO - Christopher Guiffre |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|